Latest Issue

Pulmonary & Nasal Drug Delivery167

Issue No #167 Nov 2024 November 12th, 2024

Inside the magazine

REFORMULATING pMDIS WITH NEXT-GENERATION SUSTAINABLE PROPELLANTS

REFORMULATING pMDIS WITH NEXT-GENERATION SUSTAINABLE PROPELLANTS

Ross Errington and Simon Gardner, discuss sustainability and the reformulation of pMDIs with low-GWP propellants.

INNOVATIVE ACOUSTIC NEBULISER TECHNOLOGY

INNOVATIVE ACOUSTIC NEBULISER TECHNOLOGY

Andrea Cusack, Elijah Nazarzadeh and John Pritchard share insights into the company’s innovative nebuliser platform, designed to overcome the technical restrictions of current technologies that limit the delivery of advanced medicines to the lungs. They also share an update on the development of new digital features for the Nebu-Flow product range.

INTERVIEW: PUREHALE<sup>®</sup> AND THE FUTURE OF FINE MIST DISPENSERS FOR UPPER AIRWAY TREATMENTS

INTERVIEW: PUREHALE^® AND THE FUTURE OF FINE MIST DISPENSERS FOR UPPER AIRWAY TREATMENTS

Julien Storz and Giulia Mueller discuss the latest trends and treatment options available for upper airway conditions, along with the many benefits offered by Aptar Pharma’s advanced PureHale^® systems to manufacturers.

TRACE ANALYTICAL CONSIDERATIONS WHEN REFORMULATING pMDIS WITH NEXT-GENERATION LOW-GWP PROPELLANT SYSTEMS

TRACE ANALYTICAL CONSIDERATIONS WHEN REFORMULATING pMDIS WITH NEXT-GENERATION LOW-GWP PROPELLANT SYSTEMS

Mark Parry, John McLaughlin and Tino Otte discuss the necessary studies required to understand the nitrosamine formation and leachables profiles of new pMDI propellants with lower global warming potentials as part of the pharmaceutical industry’s drive to reduce its emissions and environmental impact.

BREEASE – DESIGNED TO ALLEVIATE BREATHING FOR INFANTS AND TODDLERS

Dr Marie-Christine Klein

BREEASE – DESIGNED TO ALLEVIATE BREATHING FOR INFANTS AND TODDLERS

Marie-Christine Klein, Christian Weyler and Dr Fredrik Bokvist, discuss the effects of air pollution on health – and how the Breease pacifier could help babies and young children.

ENVIRONMENTAL BENEFITS OF BEDSIDE IONIC NITRIC OXIDE GENERATION

ENVIRONMENTAL BENEFITS OF BEDSIDE IONIC NITRIC OXIDE GENERATION

David Webster and Mark Rimkus consider the environmental impact of traditional high-pressure storage systems for nitric oxide and highlight the benefits associated with bedside ionic generation.

IMPROVING AEROSOL DELIVERY: NANOSUSPENSION & MESH TECHNOLOGY

Edgar Hernan Cuevas Brun

HCmed Innovations

IMPROVING AEROSOL DELIVERY: NANOSUSPENSION & MESH TECHNOLOGY

Edgar Hernan Cuevas Brun and Yuchi Chen, discuss how the combination of Formosa’s APNT formulation technology and HCmed’s AdheResp smart breath-actuated mesh nebuliser can work together to offer significant benefits to the aerosolisation of difficult solution-based formulations for inhalation.

STRATEGIES FOR SELECTING THE RIGHT CDMO FOR NASAL DRUG DELIVERY

Catalent Pharma Solutions

STRATEGIES FOR SELECTING THE RIGHT CDMO FOR NASAL DRUG DELIVERY

Mark Ignaczak explores the current nasal drug delivery landscape and outlines key considerations for choosing the right CDMO to ensure the success of nasal drug projects.

THE pMDI DILEMMA: MANAGING PATIENT NEEDS, HEALTH AND THE PLANET

Kindeva Drug Delivery

THE pMDI DILEMMA: MANAGING PATIENT NEEDS, HEALTH AND THE PLANET

Nick Smalley discusses the balancing act involved in meeting patients’ therapeutic needs while protecting the planet when it comes to pMDI development.

INTERVIEW with ALASTAIR WILLOUGHBY

Alastair Willoughby

Team Consulting

INTERVIEW with ALASTAIR WILLOUGHBY

CPHI Milan this year included a key discussion led by Team Consulting’s Alastair Willoughby on “Understanding the Problem of Decarbonisation in Drug Delivery”; one of the industry’s critical challenges.

Top